Defragmenting R&D: Lessons from the Pioneers

Effective Research and Development (R&D) is the lifeblood of the pharmaceutical industry. The funding of this highly risky and long-term activity had until the last decade or so been primarily left to well-capitalised and integrated global Big Pharma companies. A more recent era of cheap money has now changed all that. Since the market crash […]

Medical Affairs: Influencers of the Future

Medical Affairs is in the midst of an exciting metamorphosis. The global shift towards evidence-based care is creating new opportunities for the function to play a more strategic role within pharmaceutical companies. As medicines become more targeted and the evidence base more nuanced, Medical Affairs has the potential to become one of the key influencers […]